Turn the dose knob until it stops and the [1] icon is shown in the dose window
Administering tirzepatide involves a once-weekly injection, typically alongside a consistent management plan that includes a diabetes friendly diet and regular exercise
Key Points Tirzepatide is approved for weight loss, type 2 diabetes, and sleep apnea Healthcare providers start tirzepatide at 2.5 mg weekly and increase the dose gradually every 4 weeks to minimize side effects Higher doses of tirzepatide may produce greater weight loss results and lower blood sugar levels, but individual results vary Studies show that tirzepatide works better combined with diet and lifestyle changes Tirzepatide, available as Mounjaro and Zepbound, has shown impressive results in clinical trials with 15-20% weight loss, improved A1C levels for people with type 2 diabetes, and even benefits for sleep apnea
[cited 2021 Feb 26]
Your healthcare provider will regularly assess how well this treatment approach is working for you and whether it continues to be the best approach
For example, other antidiabetic agents (such as insulin, metformin, glyburide, sitagliptin, and canagliflozin) taken along with GLP-1 RAs potentiate hypoglycemic risk and may necessitate dose adjustments
